MedPath

Ethacrynic Acid

Ethacrynic Acid Tablets, USP (25 mg)

Approved
Approval ID

b9bc3907-bfa7-4d9f-90d9-c2097230f7e4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 30, 2023

Manufacturers
FDA

Amneal Pharmaceuticals NY LLC

DUNS: 123797875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ethacrynic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69238-1126
Application NumberANDA208805
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ethacrynic Acid
Product Specifications
Route of AdministrationORAL
Effective DateDecember 30, 2023
FDA Product Classification

INGREDIENTS (5)

ETHACRYNIC ACIDActive
Quantity: 25 mg in 1 1
Code: M5DP350VZV
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ethacrynic Acid - FDA Drug Approval Details